The rapid, massive growth of COVID-19 authors in the scientific literature

JPA Ioannidis, M Salholz-Hillel… - Royal Society …, 2021 - royalsocietypublishing.org
We examined the extent to which the scientific workforce in different fields was engaged in
publishing COVID-19-related papers. According to Scopus (data cut, 1 August 2021), 210 183 …

[HTML][HTML] Results dissemination from completed clinical trials conducted at German university medical centers remained delayed and incomplete. The 2014–2017 …

…, E Nury, JJ Meerpohl, M Salholz-Hillel… - Journal of Clinical …, 2022 - Elsevier
Objective Timely publication of clinical trial results is central for evidence-based medicine. In
this follow-up study we benchmark the performance of German university medical centers (…

Massive covidization of research citations and the citation elite

…, E Bendavid, M Salholz-Hillel… - Proceedings of the …, 2022 - National Acad Sciences
Massive scientific productivity accompanied the COVID-19 pandemic. We evaluated the
citation impact of COVID-19 publications relative to all scientific work published in 2020 to 2021 …

Results publications are inadequately linked to trial registrations: An automated pipeline and evaluation of German university medical centers

M Salholz-Hillel, D Strech, BG Carlisle - Clinical Trials, 2022 - journals.sagepub.com
Background/Aims Informed clinical guidance and health policy relies on clinicians,
policymakers, and guideline developers finding comprehensive clinical evidence and linking …

[HTML][HTML] Is the future of peer review automated?

…, MA Gazda, H Kilicoglu, EM Prager, M Salholz-Hillel… - BMC research …, 2022 - Springer
The rising rate of preprints and publications, combined with persistent inadequate reporting
practices and problems with study design and execution, have strained the traditional peer …

Statistical guidance to authors at top-ranked journals across scientific disciplines

TE Hardwicke, M Salholz-Hillel, M Malički… - The American …, 2023 - Taylor & Francis
Scientific journals may counter the misuse, misreporting, and misinterpretation of statistics
by providing guidance to authors. We described the nature and prevalence of statistical …

[HTML][HTML] Dissemination of Registered COVID-19 Clinical Trials (DIRECCT): a cross-sectional study

M Salholz-Hillel, M Pugh-Jones, N Hildebrand… - BMC medicine, 2023 - Springer
Background The results of clinical trials should be completely and rapidly reported during
public health emergencies such as COVID-19. This study aimed to examine when, and where, …

Understanding the provenance and quality of methods is essential for responsible reuse of FAIR data

…, F Naudet, U Mansmann, M Salholz-Hillel… - Nature medicine, 2024 - nature.com
FAIR principles provide a minimal set of guiding principles for making data findable, accessible,
interoperable and reusable 1. Open data are not necessarily FAIR, and FAIR data are …

Results availability and timeliness of registered COVID-19 clinical trials: interim cross-sectional results from the DIRECCT study

M Salholz-Hillel, P Grabitz, M Pugh-Jones, D Strech… - BMJ open, 2021 - bmjopen.bmj.com
Objective To examine how and when the results of COVID-19 clinical trials are disseminated.
Design Cross-sectional study. Setting The COVID-19 clinical trial landscape. Participants …

The rapid, massive infection of the scientific literature and authors by COVID-19

JPA Ioannidis, M Salholz-Hillel, KW Boyack, J Baas - bioRxiv, 2020 - biorxiv.org
Importance COVID-19 is a major global crisis and the scientific community has been mobilized
to deal with this crisis. Objective To estimate the extent to which the scientific workforce in …